Top 20 Companies in The Restless Leg Syndrome (RLS) Market 2025: Preparing for the Unpredictable Future
Indroduction: The Restless Leg Syndrome (RLS) Market is experiencing notable growth due to the rising prevalence of neurological and sleep-related disorders, particularly among the aging population. RLS, also known as Willis-Ekbom disease, is a chronic neurological condition characterized by an uncontrollable urge to move the legs, often leading to sleep disruption and reduced quality of life. Increasing awareness of the disorder, advancements in diagnostic techniques, and the availability of effective treatment options such as dopaminergic agents, anticonvulsants, and emerging device-based therapies are driving the expansion of this market. Furthermore, ongoing research, patient advocacy initiatives, and the integration of digital health tools for symptom tracking and management are shaping the future landscape of the RLS market. The Global Restless Leg Syndrome Market Size is Expected to Grow from USD 691.58 Million in 2024 to USD 1197.68 Million by 2035,...